Skip to content
Home/Companies/Biotech/CytoSeek

CytoSeek

Biotech·UK·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns CytoSeek?

CytoSeek is a British Biotech company, currently owned by Future Planet Capital since 2019.

Hand-verified · updated 2026-08-11

Open JSON · CC-BY
Future Planet Capital
Investor
Future Planet Capital
UK Innovation and Science Seed Fund · 2012 · VC

Key facts

HQUK
SectorBiotech
StatusActive

More from UK Innovation and Science Seed Fund

Other portfolio companies in the same fund.

52North Health
52North Health
Active
HealthTechUK
Akrivia Health
Akrivia Health
Active
HealthTechUK
Antiverse
Antiverse
Active
BiotechUK
CellCentric
CellCentric
Active
BiotechUK
Clare Sys
Clare Sys
Active
Deep TechUK
Crescendo Biologics
Crescendo Biologics
Active
BiotechUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns CytoSeek?

CytoSeek is currently owned by Future Planet Capital, through UK Innovation and Science Seed Fund, since 2019.

When did Future Planet Capital acquire CytoSeek?

Future Planet Capital acquired CytoSeek in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue